Secteur ProMIS Neurosciences, Inc.

Actions

PMN

CA74346M5054

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX 19:26:34 30/06/2026 Varia. 5j. Varia. 1 janv.
12,76 USD +18,65% Graphique intraday de ProMIS Neurosciences, Inc. +16,93% +83,15%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
+18,65%+16,93%+20,08%-2,95%+83,15%+3,35%-87,11%-95,05%-93,06% 96,4 M
+3,31%-0,20%+13,01%+32,37%+13,20%+72,71%+128,31%+218,07%+7 017,54% 55,78 Md
-1,32%+16,55%+22,55%+28,36%+37,37%+89,14%+101,41%-21,18% - 55,66 Md
-0,86%+3,35%+2,14%+9,87%-1,62%-12,03%-13,22%-58,17% - 23,84 Md
+2,74%+5,35%+1,49%-29,81%-38,17%+6,93%+410,00%+278,11%+991,38% 22,7 Md
+4,45%+5,06%+9,52%+6,31%-11,45%+36,50%-30,43%-30,05%+48,35% 16,12 Md
+0,66%+6,41%+8,65%+30,23%+24,64%+23,95%+185,87%+199,84%+599,49% 13,64 Md
+5,51%+22,37%+44,09%+109,38%+185,11%+171,85%+333,54%+1 617,14%+633,62% 14,8 Md
+1,31%+3,88%+10,83%+5,54%-8,41%+76,23%+130,89%+447,53% - 12,16 Md
-1,34%+7,50%+16,73%+36,59%+35,36%+160,32%+163,67%+334,61%+806,32% 11,85 Md
+2,60%+4,09%+10,59%+44,26%+25,27%+426,36%+133,22%+0,42%+1 463,25% 11,34 Md
+3,32%+4,11%-5,57%-12,63%-15,18%-30,29%+491,04%+98,86%+90,93% 11,11 Md
-0,03%+0,02%+32,75%+27,66%+22,75%+61,82%+192,79% - - 9,76 Md
+0,17%+19,60%+20,93%+31,46%+342,17%+231,63%+214,93%-38,69% - 9,19 Md
+2,32%+13,22%+20,28%+7,04%+27,50%+80,96%+17,80%+161,35% - 8,33 Md
+0,44%-6,76%+28,28%+99,23%+176,22%+504,48%+703,46%-47,99%-25,52% 7,83 Md
+0,73%-0,66%-2,41%+13,02%+6,19%+18,03%+70,73%+2,64%+239,07% 7,11 Md
-8,22%+4,24%-11,16%-19,02%-42,13% - - - - 7,56 Md
+0,73%+8,13%+16,99%+28,69%+25,86%+56,52%+635,28%+91,83% - 6,59 Md
+2,28%+9,80%+14,54%+12,66%+12,25%+455,29%+236,74%+391,62% - 6,62 Md
Moyenne +1,86%+4,64%+13,71%+22,91%+45,00%+128,09%+211,52%+197,27%+1 070,12% 15,6 Md
Moyenne pondérée par Capi. +1,18%+4,58%+14,06%+24,20%+32,67%+100,29%+180,71%+191,38%+2 673,89%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action PMN
  4. Secteur ProMIS Neurosciences, Inc.